Author
Listed:
- Jens Luebeck
(University of California at San Diego
University of California at San Diego)
- Alvin Wei Tian Ng
(University of Cambridge
University of Cambridge)
- Patricia C. Galipeau
(Fred Hutchinson Cancer Center)
- Xiaohong Li
(Fred Hutchinson Cancer Center)
- Carissa A. Sanchez
(Fred Hutchinson Cancer Center)
- Annalise C. Katz-Summercorn
(University of Cambridge)
- Hoon Kim
(Sungkyunkwan University
Sungkyunkwan University)
- Sriganesh Jammula
(University of Cambridge)
- Yudou He
(UC San Diego Health
University of California at San Diego
University of California at San Diego)
- Scott M. Lippman
(UC San Diego Health)
- Roel G. W. Verhaak
(The Jackson Laboratory for Genomic Medicine)
- Carlo C. Maley
(Arizona State University)
- Ludmil B. Alexandrov
(UC San Diego Health
University of California at San Diego
University of California at San Diego)
- Brian J. Reid
(Fred Hutchinson Cancer Center
University of Washington
University of Washington)
- Rebecca C. Fitzgerald
(University of Cambridge)
- Thomas G. Paulson
(Fred Hutchinson Cancer Center)
- Howard Y. Chang
(Stanford University
Stanford University)
- Sihan Wu
(University of Texas Southwestern Medical Center)
- Vineet Bafna
(University of California at San Diego
University of California at San Diego)
- Paul S. Mischel
(Stanford University School of Medicine
Stanford University)
Abstract
Oncogene amplification on extrachromosomal DNA (ecDNA) drives the evolution of tumours and their resistance to treatment, and is associated with poor outcomes for patients with cancer1–6. At present, it is unclear whether ecDNA is a later manifestation of genomic instability, or whether it can be an early event in the transition from dysplasia to cancer. Here, to better understand the development of ecDNA, we analysed whole-genome sequencing (WGS) data from patients with oesophageal adenocarcinoma (EAC) or Barrett’s oesophagus. These data included 206 biopsies in Barrett’s oesophagus surveillance and EAC cohorts from Cambridge University. We also analysed WGS and histology data from biopsies that were collected across multiple regions at 2 time points from 80 patients in a case–control study at the Fred Hutchinson Cancer Center. In the Cambridge cohorts, the frequency of ecDNA increased between Barrett’s-oesophagus-associated early-stage (24%) and late-stage (43%) EAC, suggesting that ecDNA is formed during cancer progression. In the cohort from the Fred Hutchinson Cancer Center, 33% of patients who developed EAC had at least one oesophageal biopsy with ecDNA before or at the diagnosis of EAC. In biopsies that were collected before cancer diagnosis, higher levels of ecDNA were present in samples from patients who later developed EAC than in samples from those who did not. We found that ecDNAs contained diverse collections of oncogenes and immunomodulatory genes. Furthermore, ecDNAs showed increases in copy number and structural complexity at more advanced stages of disease. Our findings show that ecDNA can develop early in the transition from high-grade dysplasia to cancer, and that ecDNAs progressively form and evolve under positive selection.
Suggested Citation
Jens Luebeck & Alvin Wei Tian Ng & Patricia C. Galipeau & Xiaohong Li & Carissa A. Sanchez & Annalise C. Katz-Summercorn & Hoon Kim & Sriganesh Jammula & Yudou He & Scott M. Lippman & Roel G. W. Verha, 2023.
"Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus,"
Nature, Nature, vol. 616(7958), pages 798-805, April.
Handle:
RePEc:nat:nature:v:616:y:2023:i:7958:d:10.1038_s41586-023-05937-5
DOI: 10.1038/s41586-023-05937-5
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Shixiang Wang & Chen-Yi Wu & Ming-Ming He & Jia-Xin Yong & Yan-Xing Chen & Li-Mei Qian & Jin-Ling Zhang & Zhao-Lei Zeng & Rui-Hua Xu & Feng Wang & Qi Zhao, 2024.
"Machine learning-based extrachromosomal DNA identification in large-scale cohorts reveals its clinical implications in cancer,"
Nature Communications, Nature, vol. 15(1), pages 1-17, December.
- Alvin Wei Tian Ng & Dylan Peter McClurg & Ben Wesley & Shahriar A. Zamani & Emily Black & Ahmad Miremadi & Olivier Giger & Rogier ten Hoopen & Ginny Devonshire & Aisling M. Redmond & Nicola Grehan & S, 2024.
"Disentangling oncogenic amplicons in esophageal adenocarcinoma,"
Nature Communications, Nature, vol. 15(1), pages 1-13, December.
- Katelyn L. Mortenson & Courtney Dawes & Emily R. Wilson & Nathan E. Patchen & Hailey E. Johnson & Jason Gertz & Swneke D. Bailey & Yang Liu & Katherine E. Varley & Xiaoyang Zhang, 2024.
"3D genomic analysis reveals novel enhancer-hijacking caused by complex structural alterations that drive oncogene overexpression,"
Nature Communications, Nature, vol. 15(1), pages 1-15, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:616:y:2023:i:7958:d:10.1038_s41586-023-05937-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.